Looks like no other offers for Mayne. That should clear the road for SUPG receiving the acceleration clause of 14M. I'm just wondering if then the Nipent EU deal can be consummated? We could see a little buying on that news. Supg started quarter off with 50M+ and third quarter realized 14M for Nipent and 5M from JNJ and 1M for 2nd quarter sales of Dacogen. No large payouts this quarter...believe we see a decent cash position increase. The thing I see important about having the strong balance sheet gives them leverage on their pipeline if any partner comes looking at MP-470.
As I understand it, the $14m was paid upon the closing of the transaction and an additional $20m deferred based on achieving milestones (for a total consideration of $34m)
Since Mayne was aquired, the $20m payment may be accelerated based on the 8-k language.
Additionally, in one the last con calls, Mancuso stated that they expected to close the Nipent EU deal with Mayne by the end of Q3. So it should be done and news should be announced shortly. Anyone have any insight on that?